164 related articles for article (PubMed ID: 9723122)
1. Modulation of central serotonergic neurotransmission by risperidone: underlying mechanism(s) and significance of action.
Hertel P; Lindblom N; Nomikos GG; Svensson TH
Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jul; 22(5):815-34. PubMed ID: 9723122
[TBL] [Abstract][Full Text] [Related]
2. Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine.
Hertel P; Nomikos GG; Svensson TH
Br J Pharmacol; 1997 Dec; 122(8):1639-46. PubMed ID: 9422809
[TBL] [Abstract][Full Text] [Related]
3. Risperidone dose-dependently increases extracellular concentrations of serotonin in the rat frontal cortex: role of alpha 2-adrenoceptor antagonism.
Hertel P; Nomikos GG; Schilström B; Arborelius L; Svensson TH
Neuropsychopharmacology; 1997 Jul; 17(1):44-55. PubMed ID: 9194049
[TBL] [Abstract][Full Text] [Related]
4. Receptor-mediated regulation of serotonin output in the rat dorsal raphe nucleus: effects of risperidone.
Hertel P; Lindblom N; Nomikos GG; Svensson TH
Psychopharmacology (Berl); 2001 Jan; 153(3):307-14. PubMed ID: 11271402
[TBL] [Abstract][Full Text] [Related]
5. The antipsychotic drug risperidone interacts with auto- and hetero-receptors regulating serotonin output in the rat frontal cortex.
Hertel P; Nomikos GG; Svensson TH
Neuropharmacology; 1999 Aug; 38(8):1175-84. PubMed ID: 10462130
[TBL] [Abstract][Full Text] [Related]
6. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei.
Hervás I; Bel N; Fernández AG; Palacios JM; Artigas F
Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):315-22. PubMed ID: 9774218
[TBL] [Abstract][Full Text] [Related]
7. 5-HT1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram.
Arborelius L; Nomikos GG; Grillner P; Hertel P; Höök BB; Hacksell U; Svensson TH
Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):157-65. PubMed ID: 7477438
[TBL] [Abstract][Full Text] [Related]
8. The role of 5-HT1A autoreceptors and alpha1-adrenoceptors in the modulation of 5-HT release--III. Clozapine and the novel putative antipsychotic S 16924.
Bengtsson HJ; Kullberg A; Millan MJ; Hjorth S
Neuropharmacology; 1998; 37(3):349-56. PubMed ID: 9681933
[TBL] [Abstract][Full Text] [Related]
9. Effects of idazoxan on dorsal raphe 5-hydroxytryptamine neuronal function.
Garratt JC; Crespi F; Mason R; Marsden CA
Eur J Pharmacol; 1991 Jan; 193(1):87-93. PubMed ID: 1710990
[TBL] [Abstract][Full Text] [Related]
10. In vivo assessment of the midbrain raphe nuclear regulation of serotonin release in the hamster suprachiasmatic nucleus.
Dudley TE; Dinardo LA; Glass JD
J Neurophysiol; 1999 Apr; 81(4):1469-77. PubMed ID: 10200183
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the activity of central serotoninergic neurons by novel serotonin1A receptor agonists and antagonists: a comparison to adrenergic and dopaminergic neurons in rats.
Gobert A; Lejeune F; Rivet JM; Audinot V; Newman-Tancredi A; Millan MJ
J Pharmacol Exp Ther; 1995 Jun; 273(3):1032-46. PubMed ID: 7791073
[TBL] [Abstract][Full Text] [Related]
12. Systemic uptake inhibition decreases serotonin release via somatodendritic autoreceptor activation.
Rutter JJ; Gundlah C; Auerbach SB
Synapse; 1995 Jul; 20(3):225-33. PubMed ID: 7570354
[TBL] [Abstract][Full Text] [Related]
13. The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram.
Arborelius L; Nomikos GG; Hertel P; Salmi P; Grillner P; Höök BB; Hacksell U; Svensson TH
Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):630-40. PubMed ID: 8738296
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxtryptamine system.
Haddjeri N; de Montigny C; Blier P
Br J Pharmacol; 1997 Mar; 120(5):865-75. PubMed ID: 9138693
[TBL] [Abstract][Full Text] [Related]
15. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex.
Dawson LA; Nguyen HQ; Smith DL; Schechter LE
J Psychopharmacol; 2002 Jun; 16(2):145-52. PubMed ID: 12095073
[TBL] [Abstract][Full Text] [Related]
16. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
[TBL] [Abstract][Full Text] [Related]
17. Effects of sustained (+/-)pindolol administration on serotonin neurotransmission in rats.
Haddjeri N; Blier P
J Psychiatry Neurosci; 2000 Sep; 25(4):378-88. PubMed ID: 11022403
[TBL] [Abstract][Full Text] [Related]
18. Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain.
Corradetti R; Laaris N; Hanoun N; Laporte AM; Le Poul E; Hamon M; Lanfumey L
Br J Pharmacol; 1998 Feb; 123(3):449-62. PubMed ID: 9504386
[TBL] [Abstract][Full Text] [Related]
19. Effect of sustained administration of the 5-HT1A receptor agonist flesinoxan on rat 5-HT neurotransmission.
Haddjeri N; Ortemann C; de Montigny C; Blier P
Eur Neuropsychopharmacol; 1999 Sep; 9(5):427-40. PubMed ID: 10523050
[TBL] [Abstract][Full Text] [Related]
20. Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535.
Lejeune F; Millan MJ
Synapse; 1998 Oct; 30(2):172-80. PubMed ID: 9723787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
